Concepedia

Leiming Wang

LW

Statistics

Publications

10

Citations

380

H-Index

10

Active since

2012

Affiliations

Shenzhen Bay Laboratory(Current)

The University of Texas at San Antonio Health Science Center

Union Hospital

Xuzhou Medical College

Jilin University

Leiming Wang is an author at Shenzhen Bay Laboratory specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

2012–2024

10

Publications

10

Small molecule JQ1 promotes prostate cancer invasion via BET-independent inactivation of FOXA1

Leiming Wang, Mafei Xu, Chung‐Yang Kao et al. · Journal of Clinical Investigation · 2019 · 72 citations · Full text

, , +17

Ketamine Inhibits Ovarian Cancer Cell Growth by Regulating the lncRNA-PVT1/EZH2/p57 Axis

Tao Li, Jie Yang, Ben Yang et al. · Frontiers in Genetics · 2021 · 65 citations · Full text

, , +15

Engineering LNPs with polysarcosine lipids for mRNA delivery

Diana D. Kang, Xucheng Hou, Leiming Wang et al. · Bioactive Materials · 2024 · 59 citations · Full text

, , +17

Circular RNA UBAP2 facilitates the cisplatin resistance of triple-negative breast cancer via microRNA-300/anti-silencing function 1B histone chaperone/PI3K/AKT/mTOR axis

Leiming Wang, Xi Yang, Fei Zhou et al. · Bioengineered · 2022 · 41 citations · Full text

, , +17

Discovery of a novel small-molecule inhibitor of Fam20C that induces apoptosis and inhibits migration in triple negative breast cancer

Rongyan Zhao, Leilei Fu, Zhaoxin Yuan et al. · European Journal of Medicinal Chemistry · 2020 · 31 citations · Full text

, , +13

1–5 of 10